Brief: Innovative Pharmaceutical Biotech Sees Profit Attributed For 6-months HK$100 Mln - HK$200 Mln
Nov 27 (Reuters) - Innovative Pharmaceutical Biotech
0399.HK :
* SEES PROFIT ATTRIBUTED FOR SIX MONTHS IN RANGE BETWEEN
HK$100
MILLION AND HK $200 MILLION
* EXPECTED RESULT DUE TO NON-CASH ITEM RESULTED FROM
COMPLETION OF
MODIFICATION OF CONVERTIBLE BONDS DURING PERIOD
Further company coverage: 0399.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU